Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership


All
13F
13D/G
Other
Tags
CC transcript
ASTRAZENECA PLC (AZN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2023 SC 13G/A ASTRAZENECA PLC reports a 3.4% stake in * Aridis Pharmaceuticals, Inc.
02/10/2023 SC 13G/A ASTRAZENECA PLC reports a 4.8% stake in PIERIS PHARMACEUTICALS, INC.
01/24/2023 SC 13G/A BlackRock Inc. reports a 9.6% stake in ASTRAZENECA PLC
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/27/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2021 SC 13G ASTRAZENECA PLC reports a 5.2% stake in ADC Therapeutics SA
02/10/2021 SC 13G/A ASTRAZENECA PLC reports a 0% stake in Moderna, Inc.
02/03/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2020 SC 13D ASTRAZENECA PLC reports a 16.7% stake in AEVI GENOMIC MEDICINE, INC.
02/05/2020 SC 13G/A BlackRock Inc. reports a 8% stake in ASTRAZENECA PLC
01/30/2020 SC 13G ASTRAZENECA PLC reports a 28.7% stake in Viela Bio Inc.
01/27/2020 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 5.9% stake in ASTRAZENECA PLC
10/25/2019 SC 13D ASTRAZENECA PLC reports a 9.5% stake in INNATE PHARMA S.A.
02/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/30/2019 SC 13G ASTRAZENECA PLC reports a 7.8% stake in Moderna, Inc.
10/29/2018 SC 13D ASTRAZENECA PLC reports a 12.6% stake in PHASEBIO PHARMACEUTICALS INC.
10/12/2018 SC 13D/A ASTRAZENECA PLC reports a 16.6% stake in ENTASIS THERAPEUTICS HOLDINGS INC.
10/05/2018 SC 13D ASTRAZENECA PLC reports a 16.6% stake in ENTASIS THERAPEUTICS HOLDINGS INC.
02/08/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/08/2018 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 6.4% stake in ASTRAZENECA PLC
01/30/2018 SC 13G/A BlackRock Inc. reports a 8.3% stake in ASTRAZENECA PLC
12/11/2017 SC 13D/A ASTRAZENECA PLC reports a 5.7% stake in ALBIREO PHARMA, INC.
02/10/2017 SC 13G ASTRAZENECA PLC reports a 10.7% stake in Catabasis Pharmaceuticals, Inc.
02/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/19/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/14/2016 SC 13D ASTRAZENECA PLC reports a 16% stake in ALBIREO PHARMA, INC.
02/16/2016 SC 13G ASTRAZENECA PLC reports a 7.3% stake in INOTEK PHARMACEUTICALS CORPORATION
02/11/2016 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 6.8% stake in ASTRAZENECA PLC
02/10/2016 SC 13G/A BlackRock Inc. reports a 10.2% stake in ASTRAZENECA PLC
02/05/2016 SC 13G/A ASTRAZENECA PLC reports a 0% stake in APPLIED GENETIC TECHNOLOGIES CORPORATION
01/25/2016 SC 13G/A BlackRock Inc. reports a 9.6% stake in ASTRAZENECA PLC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy